Zydus Lifesciences Limited (ZYDUSLIFE.BO)
INR 859.55
(2.64%)
INR 859.55
(2.64%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 125.21 Billion INR | 21.34% |
| 2023 | 103.18 Billion INR | 14.54% |
| 2022 | 90.08 Billion INR | -0.5% |
| 2021 | 90.54 Billion INR | 4.52% |
| 2020 | 86.62 Billion INR | 11.08% |
| 2019 | 77.98 Billion INR | 7.74% |
| 2018 | 72.38 Billion INR | 30.25% |
| 2017 | 55.57 Billion INR | -9.61% |
| 2016 | 61.48 Billion INR | 15.1% |
| 2015 | 53.41 Billion INR | 21.32% |
| 2014 | 44.02 Billion INR | 11.48% |
| 2013 | 39.49 Billion INR | 13.2% |
| 2012 | 34.88 Billion INR | 16.71% |
| 2011 | 29.89 Billion INR | 24.78% |
| 2010 | 23.95 Billion INR | 21.55% |
| 2009 | 19.7 Billion INR | 33.56% |
| 2008 | 14.75 Billion INR | 28.51% |
| 2007 | 11.48 Billion INR | 31.01% |
| 2006 | 8.76 Billion INR | 15.48% |
| 2005 | 7.59 Billion INR | 9.13% |
| 2004 | 6.95 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | 37.54 Billion INR | 30.6% |
| 2024 Q2 | 27.84 Billion INR | -17.57% |
| 2024 FY | 127.93 Billion INR | 23.98% |
| 2024 Q3 | 28.75 Billion INR | 3.25% |
| 2024 Q1 | 33.78 Billion INR | 16.19% |
| 2023 Q2 | 23.48 Billion INR | -2.71% |
| 2023 FY | 103.18 Billion INR | 14.54% |
| 2023 Q4 | 29.07 Billion INR | 9.75% |
| 2023 Q3 | 26.49 Billion INR | 12.83% |
| 2023 Q1 | 24.13 Billion INR | 22.87% |
| 2022 Q1 | 25.38 Billion INR | 18.51% |
| 2022 FY | 90.08 Billion INR | -0.5% |
| 2022 Q4 | 19.64 Billion INR | -10.55% |
| 2022 Q3 | 21.95 Billion INR | -4.59% |
| 2022 Q2 | 23.01 Billion INR | -9.35% |
| 2021 Q2 | 23.57 Billion INR | 5.06% |
| 2021 FY | 90.54 Billion INR | 4.52% |
| 2021 Q1 | 22.44 Billion INR | 23.18% |
| 2021 Q4 | 21.42 Billion INR | -10.37% |
| 2021 Q3 | 23.9 Billion INR | 1.37% |
| 2020 Q2 | 20.87 Billion INR | -6.67% |
| 2020 Q1 | 22.36 Billion INR | 31.86% |
| 2020 FY | 86.62 Billion INR | 11.08% |
| 2020 Q4 | 18.22 Billion INR | -20.44% |
| 2020 Q3 | 22.9 Billion INR | 9.7% |
| 2019 Q2 | 19.69 Billion INR | 3.26% |
| 2019 Q4 | 16.96 Billion INR | -23.78% |
| 2019 Q1 | 19.07 Billion INR | -11.99% |
| 2019 Q3 | 22.25 Billion INR | 13.02% |
| 2019 FY | 77.98 Billion INR | 7.74% |
| 2018 Q1 | 13.6 Billion INR | -11.86% |
| 2018 Q3 | 21.41 Billion INR | 0.73% |
| 2018 Q4 | 21.66 Billion INR | 1.18% |
| 2018 FY | 72.38 Billion INR | 30.25% |
| 2018 Q2 | 21.26 Billion INR | 56.26% |
| 2017 Q1 | 15.13 Billion INR | -2.79% |
| 2017 FY | 55.57 Billion INR | -9.61% |
| 2017 Q4 | 15.43 Billion INR | 9.34% |
| 2017 Q3 | 14.11 Billion INR | -6.5% |
| 2017 Q2 | 15.09 Billion INR | -0.2% |
| 2016 Q2 | 15.08 Billion INR | 2.7% |
| 2016 FY | 61.48 Billion INR | 15.1% |
| 2016 Q3 | 15.07 Billion INR | -0.06% |
| 2016 Q1 | 14.68 Billion INR | -1.63% |
| 2016 Q4 | 15.56 Billion INR | 3.26% |
| 2015 Q2 | 12.41 Billion INR | 2.85% |
| 2015 Q3 | 14.06 Billion INR | 13.33% |
| 2015 Q4 | 14.92 Billion INR | 6.1% |
| 2015 Q1 | 12.07 Billion INR | 1.0% |
| 2015 FY | 53.41 Billion INR | 21.32% |
| 2014 Q3 | 11.17 Billion INR | 9.36% |
| 2014 FY | 44.02 Billion INR | 11.48% |
| 2014 Q4 | 11.95 Billion INR | 6.93% |
| 2014 Q2 | 10.22 Billion INR | -4.31% |
| 2014 Q1 | 10.68 Billion INR | 29.36% |
| 2013 Q1 | 9.76 Billion INR | 161.34% |
| 2013 Q2 | 9.15 Billion INR | -6.23% |
| 2013 Q3 | 9.94 Billion INR | 8.61% |
| 2013 FY | 39.49 Billion INR | 13.2% |
| 2013 Q4 | 8.25 Billion INR | -17.01% |
| 2012 Q2 | 12.76 Billion INR | 0.0% |
| 2012 Q3 | 9.31 Billion INR | -27.03% |
| 2012 Q4 | 3.73 Billion INR | -59.86% |
| 2012 FY | 34.88 Billion INR | 16.71% |
| 2011 FY | 29.89 Billion INR | 24.78% |
| 2010 FY | 23.95 Billion INR | 21.55% |
| 2009 FY | 19.7 Billion INR | 33.56% |
| 2008 FY | 14.75 Billion INR | 28.51% |
| 2007 FY | 11.48 Billion INR | 31.01% |
| 2006 FY | 8.76 Billion INR | 15.48% |
| 2005 FY | 7.59 Billion INR | 9.13% |
| 2004 FY | 6.95 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | -367.542% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 19.053% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -907.087% |
| Granules India Limited | 16.79 Billion INR | -645.336% |
| Indoco Remedies Limited | 6.04 Billion INR | -1972.577% |
| Achyut Healthcare Limited | 4.86 Million INR | -2575728.019% |
| Ajanta Pharma Limited | 21.06 Billion INR | -494.431% |
| Alkem Laboratories Limited | 52.29 Billion INR | -139.423% |
| Alpa Laboratories Limited | 188.89 Million INR | -66186.032% |
| Brooks Laboratories Limited | 65.62 Million INR | -190712.252% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -1912.165% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -8407.303% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -3288.261% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 23.468% |
| Eris Lifesciences Limited | 10.42 Billion INR | -1100.859% |
| FDC Limited | 8.33 Billion INR | -1402.279% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | -80.574% |
| Gufic Biosciences Limited | 4.16 Billion INR | -2904.315% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | -1921.371% |
| Ipca Laboratories Limited | 29.8 Billion INR | -320.032% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -19086.779% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -64868.064% |
| Lasa Supergenerics Limited | 121.02 Million INR | -103354.516% |
| Laurus Labs Limited | 24.62 Billion INR | -408.572% |
| Lupin Limited | 123.71 Billion INR | -1.207% |
| Mankind Pharma Limited | 44.52 Billion INR | -181.241% |
| Medicamen Biotech Limited | 495.49 Million INR | -25169.882% |
| Medico Remedies Limited | 262.14 Million INR | -47664.206% |
| Megasoft Limited | 342.07 Million INR | -36503.804% |
| NATCO Pharma Limited | 25.73 Billion INR | -386.521% |
| Piramal Pharma Limited | 24.47 Billion INR | -411.673% |
| RPG Life Sciences Limited | 2.48 Billion INR | -4942.731% |
| Sigachi Industries Limited | 2 Billion INR | -6153.412% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 51.56% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -2936.689% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -13186.411% |
| Unichem Laboratories Limited | 4.86 Billion INR | -2473.747% |
| Wanbury Limited | 1.73 Billion INR | -7134.941% |
| Windlas Biotech Limited | 1.33 Billion INR | -9252.48% |
| ZIM Laboratories Limited | 1.26 Billion INR | -9783.36% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 20885.152% |
| Divi's Laboratories Limited | 32.44 Billion INR | -285.977% |
| Hester Biosciences Limited | 1.27 Billion INR | -9730.88% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -2065.756% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | -7944.229% |
| Bal Pharma Limited | 770.19 Million INR | -16157.052% |
| Strides Pharma Science Limited | 14.38 Billion INR | -770.239% |
| Venus Remedies Limited | 2.18 Billion INR | -5636.821% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -2047.204% |
| Nectar Lifesciences Limited | 2.97 Billion INR | -4112.936% |
| Shilpa Medicare Limited | 3.54 Billion INR | -3430.192% |
| Aarti Drugs Limited | 8.31 Billion INR | -1405.627% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | -2633.387% |
| Suven Life Sciences Limited | -200.79 Million INR | 62457.007% |
| Ind-Swift Limited | 2.17 Billion INR | -5663.37% |
| Valiant Laboratories Limited | -60.66 Million INR | 206500.831% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | -451.593% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -14439.131% |
| Themis Medicare Limited | 1.5 Billion INR | -8225.731% |
| Hikal Limited | 3.14 Billion INR | -3883.704% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | -167.789% |
| Sequent Scientific Limited | 2.97 Billion INR | -4103.503% |
| Novartis India Limited | 1.32 Billion INR | -9336.355% |
| Wockhardt Limited | 16.24 Billion INR | -671.004% |
| Jubilant Pharmova Limited | 19.64 Billion INR | -537.433% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -858703.679% |
| Neuland Laboratories Limited | 8.24 Billion INR | -1418.107% |
| Morepen Laboratories Limited | 6.16 Billion INR | -1932.223% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -20079.797% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -17695.638% |